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a b s t r a c t
Varicella zoster virus (VZV) is an exclusively human neurotropic alphaherpesvirus. It is unclear why
human neurons infected in vitro with VZV at low multiplicity of infection do not exhibit a cytopathic
effect (CPE) even though all VZV genes are transcribed, VZV proteins from all kinetic classes are
translated and minimal infectious virus is produced. Here, we show that the lack of VZV-induced CPE
correlates with the low abundance of viral DNA.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Varicella zoster virus (VZV), an exclusively human alphaher-
pesvirus, becomes latent in ganglionic neurons along the entire
neuraxis after primary infection. Decades later, virus can reactivate
to produce zoster and additional serious neurological and ocular
complications (Gilden et al., 2011; Nagel and Gilden, 2013). VZV
can infect neurons in vitro from multiple sources, including those
derived from human embryonic stem cells [hESC; (Markus et al.,
2011; Sloutskin et al., 2013)], human neural stem cells [hNSC;
(Pugazhenthi et al., 2011)] and human induced pluripotent stem
cells [iPSC; (Baird et al., 2014; Grose et al., 2013; Yu et al., 2013)].
Although human neurons die after VZV infection at high multi-
plicity of infection (MOI; 41103) (Markus et al., 2011;
Sloutskin et al., 2013), no CPE develops within 2 weeks after
infection at low MOI (o1103) (Baird et al., 2014; Grose et al.,
2013; Yu et al., 2013). While the absence of a CPE in neurons 5 days
after infection at low MOI has been attributed to non-productive
infection based on the absence of detectable VZV proteins
(Sloutskin et al., 2013), we have shown that VZV transcripts and
proteins as well as infectious virus are produced in neurons 14
days after low MOI infection, and ultrastructural analysis revealed
numerous empty capsids in the nuclei of VZV-infected neurons
(Grose et al., 2013; Yu et al., 2013). Furthermore, Next Generation
RNA sequencing (NextGen RNAseq) showed that every annotated
VZV open reading frame (ORF) is transcribed in human neurons 14
days post-infection (dpi), and that the abundance of VZV tran-
scripts does not differ signiﬁcantly from that found in VZV-
infected human ﬁbroblasts with extensive CPE (Baird et al.,
2014). Thus, we examined VZV DNA abundance in VZV-infected
human neurons at multiple times over a 2-week period.
Results
Virus production is both delayed and reduced in human neurons
compared to ﬁbroblasts
No virus was produced in VZV-infected neurons at 1, 3 and
7 dpi; at 14 dpi, 31 PFU/culture were detected (Fig. 1). The few PFU
detected in infected human neurons 14 dpi were not due to
residual inoculum since no infectious plaques were seen at earlier
times. In contrast, VZV-infected ﬁbroblasts began producing infec-
tious virus 1 dpi, which peaked at 2.1104 PFU/culture 7 dpi then
decreased slightly 10 dpi concomitant with cell death.
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VZV-infected human neurons do not accumulate viral DNA
To determine whether reduced and delayed VZV production
was due to limited numbers of VZV genomes available for packa-
ging, virus DNA abundance was monitored in infected human
neurons. The abundance of VZV DNA in neurons infected with a
low MOI remained constant over the 2-week study period
(Fig. 2A). Importantly, viral genomes detected at 1 dpi were likely
from virus DNA in the inoculum because a vial of Zostavax
contains 1.41010 genomes (70.11010; n¼2) and 200 PFU
(7100 PFU; n¼4) (Fig. 2B), resulting in 7107 VZV genomes
per PFU. At 1 dpi, the virus-to-cell DNA ratio was equivalent in
infected ﬁbroblasts and neurons. By 10 dpi, the virus-to-cell DNA
ratio had increased 6.7-fold in ﬁbroblasts.
Discussion
Overall, VZV DNA did not accumulate in productively infected
human neurons that lacked a CPE, but did accumulate in ﬁbro-
blasts with extensive CPE. The lack of VZV-induced CPE in human
neurons is likely due to defective viral DNA replication or rapid
degradation of VZV DNA. An absolute block in viral DNA replica-
tion in neurons is unlikely since late viral transcripts and their
proteins, for which viral DNA replication is required, were detected
(Azarkh et al., 2011; Baird et al., 2014; Grose et al., 2013; Yu et al.,
2013). VZV DNA replication was ultimately sufﬁcient to produce
31 PFU/culture, a level that would not have been detected above
the 109 input genomes. Importantly, human ﬁbroblasts infected
with the same inoculum replicated VZV genomes above input
virus DNA. A similar inhibition of HSV-1 growth and lack of CPE in
neurons obtained from explanted fetal human brain, spinal cord or
ganglia has been reported, although in these ex vivo cultures, HSV-
1 replicates and a CPE develops in non-neuronal cells (Kennedy et
al., 1983).
Materials and methods
Cells and virus
Human iPSCs (iCell neurons; Cellular Dynamics International,
Madison, WI) and human fetal lung ﬁbroblasts were cultured and
infected with cell-free VZV (Zostavax; Merck, Whitehouse Station,
NJ) at an MOIo1103 as described (Grose et al., 2013; Yu et al.,
2013).
Plaque assay
To quantify infectious virus production, both VZV-infected
human neurons and ﬁbroblasts were harvested with trypsin–EDTA
at multiple dpi, washed with PBS, diluted and co-cultivated with
uninfected ﬁbroblasts; after 3 h at 37 1C, cells were washed,
medium was replenished and plaques were visualized by crystal
violet staining and counted 7 days later.
qPCR
VZV-infected human neurons and ﬁbroblasts were harvested
on multiple dpi and at each time point, DNA was extracted
(GenElute; Sigma, St. Louis, MO) and quantiﬁed by TaqMan-
based quantitative PCR (qPCR) using 10 ng of total DNA and
primer/probe sets speciﬁc for both cell (GAPdH) and virus (VZV
ORF 29) DNA as described (Yu et al., 2013). The amount of VZV
Fig. 1. VZV production is both delayed and reduced in human neurons. Cells of
duplicate cultures of human neurons (diamonds) and ﬁbroblasts (squares) infected
with VZV at a low MOI were harvested at four time points with trypsin–EDTA,
washed with PBS, and analyzed in plaque assays by co-cultivation with uninfected
ﬁbroblasts. The inoculum was removed 3 h after co-cultivation and cell cultures
were ﬁxed, stained and plaques counted 7 days later.
Fig. 2. VZV DNA does not accumulate in VZV-infected neurons. (A) Duplicate
cultures of human neurons (diamonds) and human fetal lung ﬁbroblasts (squares)
were infected with cell-free VZV at lowMOI as in Fig. 1 and total DNAwas extracted
at four time points post-infection. Viral and cellular DNA was detected by qPCR
using primers for VZV ORF 29 and GAPdH, respectively. Relative quantities of VZV
DNA, normalized to cell DNA, were determined as detailed in the text. Error bars
represent standard deviation. (B) Viral genome copy number and PFU were
determined. DNA extractions of two separate vials of Zostavax were analyzed by
qPCR for VZV genomes; plaque assay was performed from 4 separate vials of
Zostavax.
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DNA compared to cell DNA was determined using the formula
2ΔCt , where ΔCt¼Ct(VZV ORF29)Ct(GAPdH).
DNA was isolated from Zostavax (GenElute; Sigma) and quan-
tiﬁed by TaqMan-based qPCR. Standards to determine copy num-
ber were prepared from puriﬁed VZV bacterial artiﬁcial
chromosome (BAC) DNA (Tischer et al., 2007).
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